FAP and cancer: 68Ga-labelled FAP inhibitors (FAPI) are now standard positron emission tomography-computed tomography (PET-CT) tracers, leveraging the near-universal FAP overexpression on CAFs to achieve high tumor-to-background contrast and sensitive detection of primary and metastatic lesions across multiple cancer types 187.